Fe Tubau
Overview
Explore the profile of Fe Tubau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
2019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laporte-Amargos J, Carmona-Torre F, Huguet M, Puerta-Alcalde P, Rigo-Bonnin R, Ulldemolins M, et al.
Clin Microbiol Infect
. 2024 Oct;
31(2):211-219.
PMID: 39433124
Objectives: The efficacy of extended infusions (EI) of β-lactam antibiotics for optimising outcomes in febrile neutropenia is unclear. We assessed whether the administration of β-lactams was more effective in EI...
2.
Cadenas-Jimenez I, Saiz-Escobedo L, Carrera-Salinas A, Camprubi-Marquez X, Calvo-Silveria S, Camps-Massa P, et al.
J Antimicrob Chemother
. 2024 Jul;
79(9):2194-2203.
PMID: 38946313
Objectives: This study aimed to explore the prevalence of macrolide resistance and the underlying resistance mechanisms in Haemophilus influenzae (n = 2556) and Haemophilus parainfluenzae (n = 510) collected between...
3.
Cabellos C, Guillem L, Pelegrin I, Tubau F, Ardanuy C, Gudiol F, et al.
Infect Dis (Lond)
. 2024 Jun;
56(11):974-982.
PMID: 38922314
Objectives: This study details the accumulated experience of more than 31 years using a low-dose systematic dexamethasone protocol with mannitol and antiseizure prophylaxis for the treatment of suspected pneumococcal meningitis....
4.
Calvo-Silveria S, Gonzalez-Diaz A, Grau I, Marimon J, Cercenado E, Quesada M, et al.
Lancet Reg Health Eur
. 2024 May;
41:100913.
PMID: 38737571
Background: Invasive pneumococcal disease due to serotype 3 (S3-IPD) is associated with high mortality rates and long-term adverse effects. The introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the...
5.
El Haj C, Agusti E, Benavent E, Soldevila-Boixader L, Rigo-Bonnin R, Tubau F, et al.
Antibiotics (Basel)
. 2024 Apr;
13(4).
PMID: 38667020
: As the anti-biofilm pharmacokinetic/pharmacodynamic (PK/PD) properties of antibiotics are not well-defined, we have evaluated the PK/PD indices for different regimens of ceftazidime (CAZ; with/without colistin) against biofilm. : We...
6.
Ronda M, Gumucio-Sanguino V, Shaw E, Granada R, Tubau F, Santafosta E, et al.
Antibiotics (Basel)
. 2024 Feb;
13(2).
PMID: 38391518
Information on the long-term effects of non-restrictive antimicrobial stewardship (AMS) strategies is scarce. We assessed the effect of a stepwise, multimodal, non-restrictive AMS programme on broad-spectrum antibiotic use in the...
7.
Bonilla-Moreno M, Torrecillas M, Laporte-Amargos J, Gonzalez-Diaz A, Mussetti A, Tubau F, et al.
Antimicrob Agents Chemother
. 2023 Jun;
67(11):e0027223.
PMID: 37358413
Campylobacter bacteremia is an uncommon disease that mainly occurs in immunocompromised patients and is associated with antibiotic resistance, particularly in Campylobacter coli. We report a patient with persistent blood infection...
8.
Ronda M, Padulles A, Grau I, Tubau F, Satorra P, Shaw E, et al.
J Antimicrob Chemother
. 2023 May;
78(7):1705-1710.
PMID: 37248767
Objectives: To test the hypothesis that a prospective audit and feedback (PAF) intervention combined with electronic tools will reduce carbapenem use without negatively affecting patient outcomes. Methods: A quasi-experimental, pre-intervention...
9.
Cabellos C, Guillem L, Pelegrin I, Tubau F, Ardanuy C, Gudiol F, et al.
Antimicrob Agents Chemother
. 2023 Mar;
67(4):e0005023.
PMID: 36880767
No abstract available.
10.
Vazquez-Sanchez D, Grillo S, Carrera-Salinas A, Gonzalez-Diaz A, Cuervo G, Grau I, et al.
Microorganisms
. 2022 Dec;
10(12).
PMID: 36557654
Methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA-BSI) are a significant cause of mortality. We analysed the evolution of the molecular and clinical epidemiology of MRSA-BSI (n = 784) in adult patients...